Biovaxys Technology Corp Stock Analysis
| BVAXF Stock | USD 0.05 0.01 11.78% |
Biovaxys Technology Corp is overvalued with Real Value of 0.0406 and Hype Value of 0.05. The main objective of Biovaxys Technology otc analysis is to determine its intrinsic value, which is an estimate of what Biovaxys Technology Corp is worth, separate from its market price. There are two main types of Biovaxys Technology's stock analysis: fundamental analysis and technical analysis.
The Biovaxys Technology otc stock is traded in the USA on OTCQB Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Biovaxys Technology's ongoing operational relationships across important fundamental and technical indicators.
Biovaxys |
Biovaxys OTC Stock Analysis Notes
About 19.0% of the company shares are held by company insiders. The book value of Biovaxys Technology was currently reported as 0.06. The company recorded a loss per share of 0.05. Biovaxys Technology Corp had not issued any dividends in recent years. The entity had 2:1 split on the 28th of April 2020. BioVaxys Technology Corp., a clinical biotechnology company, develops antiviral and anticancer vaccine platforms. BioVaxys Technology Corp. has a bioproduction agreement with WuXi Biologics Limited that produces SARS-CoV-2 s-proteins for BVX-0320 and CoviDTH research collaboration with The Ohio State University, Wexner School of Medicine for BVX-0320 and agreement with Bioanalytical Systems, Inc. to conduct preclinical toxicology studies for its CoviDTH immunodiagnostic. BIOVAXYS TECHNOLOGY is traded on OTC Exchange in the United States.The quote for Biovaxys Technology Corp is listed on Over The Counter exchange (i.e., OTC), and the entity is not required to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges. For more info on Biovaxys Technology Corp please contact James Passin at 604 262 8835 or go to https://www.biovaxys.com.Biovaxys Technology Corp Investment Alerts
| Biovaxys Technology had very high historical volatility over the last 90 days | |
| Biovaxys Technology has some characteristics of a very speculative penny stock | |
| Biovaxys Technology has a very high chance of going through financial distress in the upcoming years | |
| The company has a current ratio of 0.16, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Biovaxys Technology until it has trouble settling it off, either with new capital or with free cash flow. So, Biovaxys Technology's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Biovaxys Technology Corp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Biovaxys to invest in growth at high rates of return. When we think about Biovaxys Technology's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (6.46 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Biovaxys Technology Corp has accumulated about 39.05 K in cash with (5.29 M) of positive cash flow from operations. | |
| Roughly 19.0% of the company shares are held by company insiders | |
| Latest headline from thelincolnianonline.com: GH Research Shares Down 0.3 percent Heres Why |
Biovaxys Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 8.73 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Biovaxys Technology's market, we take the total number of its shares issued and multiply it by Biovaxys Technology's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 2nd of December, Biovaxys Technology shows the Downside Deviation of 5.85, risk adjusted performance of 0.0449, and Mean Deviation of 3.87. Biovaxys Technology Corp technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We have analyzed and interpolated nineteen technical drivers for Biovaxys Technology Corp, which can be compared to its peers. Please confirm Biovaxys Technology Corp jensen alpha, as well as the relationship between the potential upside and skewness to decide if Biovaxys Technology Corp is priced correctly, providing market reflects its regular price of 0.0503 per share. As Biovaxys Technology Corp appears to be a penny stock we also recommend to validate its total risk alpha numbers.Biovaxys Technology Corp Price Movement Analysis
The output start index for this execution was thirty-five with a total number of output elements of twenty-six. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Biovaxys Technology middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Biovaxys Technology Corp. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Biovaxys Technology Outstanding Bonds
Biovaxys Technology issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Biovaxys Technology Corp uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Biovaxys bonds can be classified according to their maturity, which is the date when Biovaxys Technology Corp has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Biovaxys Technology Predictive Daily Indicators
Biovaxys Technology intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Biovaxys Technology otc stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 0.0696 | |||
| Daily Balance Of Power | 1.514286 | |||
| Rate Of Daily Change | 1.12 | |||
| Day Median Price | 0.0485 | |||
| Day Typical Price | 0.0491 | |||
| Market Facilitation Index | 0.0035 | |||
| Price Action Indicator | 0.0044 | |||
| Period Momentum Indicator | 0.0053 |
Biovaxys Technology Forecast Models
Biovaxys Technology's time-series forecasting models are one of many Biovaxys Technology's otc stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Biovaxys Technology's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Biovaxys OTC Stock Analysis
OTC Stock analysis is the technique used by a trader or investor to examine and evaluate how Biovaxys Technology prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Biovaxys shares will generate the highest return on investment. We also built our otc analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual OTC such as Biovaxys Technology. By using and applying Biovaxys OTC Stock analysis, traders can create a robust methodology for identifying Biovaxys entry and exit points for their positions.
BioVaxys Technology Corp., a clinical biotechnology company, develops antiviral and anticancer vaccine platforms. BioVaxys Technology Corp. has a bioproduction agreement with WuXi Biologics Limited that produces SARS-CoV-2 s-proteins for BVX-0320 and CoviDTH research collaboration with The Ohio State University, Wexner School of Medicine for BVX-0320 and agreement with Bioanalytical Systems, Inc. to conduct preclinical toxicology studies for its CoviDTH immunodiagnostic. BIOVAXYS TECHNOLOGY is traded on OTC Exchange in the United States.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our otc stock analysis tools, you can find out how much better you can do when adding Biovaxys Technology to your portfolios without increasing risk or reducing expected return.Did you try this?
Run My Watchlist Analysis Now
My Watchlist AnalysisAnalyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |
| All Next | Launch Module |
Complementary Tools for Biovaxys OTC Stock analysis
When running Biovaxys Technology's price analysis, check to measure Biovaxys Technology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biovaxys Technology is operating at the current time. Most of Biovaxys Technology's value examination focuses on studying past and present price action to predict the probability of Biovaxys Technology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biovaxys Technology's price. Additionally, you may evaluate how the addition of Biovaxys Technology to your portfolios can decrease your overall portfolio volatility.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |